| Dr Rebecca Kortum Hartman, MD | |
|
420 E 1st St, Duluth, MN 55805-1901 | |
| (218) 786-8364 | |
| Not Available |
| Full Name | Dr Rebecca Kortum Hartman |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 420 E 1st St, Duluth, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508421249 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 73473 (Minnesota) | Primary |
| Entity Name | The Duluth Clinic Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902563638 PECOS PAC ID: 2567374283 Enrollment ID: O20031103000229 |
News Archive
On Track Innovations Ltd., a global leader in contactless smart card solutions, has received an additional order for 100,000 MediSmartTM healthcare biometric ID cards for use by Kenyan-based Smart Applications International Ltd., a provider of technology driven secure healthcare solutions.
A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces the approval from the French Drug Agency (AFFSSaPS) to enter Phase II clinical trial for clonidine Lauriad® in radiotherapy and chemotherapy-induced oral mucositis and the approval from Danish and Slovene Agencies to enter Phase I clinical trial for AMEPTM in invasive melanoma.
Menicon Co., Ltd. announced on June 16 that Menicon and Lagado Corporation based in Colorado, USA, reached an agreement for Lagado to become a wholly owned subsidiary of Menicon America Inc., effective as of June 14, 2010.
› Verified 7 days ago
| Entity Name | Essentia Health Moose Lake |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1154959880 PECOS PAC ID: 6608290333 Enrollment ID: O20200728000758 |
News Archive
On Track Innovations Ltd., a global leader in contactless smart card solutions, has received an additional order for 100,000 MediSmartTM healthcare biometric ID cards for use by Kenyan-based Smart Applications International Ltd., a provider of technology driven secure healthcare solutions.
A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces the approval from the French Drug Agency (AFFSSaPS) to enter Phase II clinical trial for clonidine Lauriad® in radiotherapy and chemotherapy-induced oral mucositis and the approval from Danish and Slovene Agencies to enter Phase I clinical trial for AMEPTM in invasive melanoma.
Menicon Co., Ltd. announced on June 16 that Menicon and Lagado Corporation based in Colorado, USA, reached an agreement for Lagado to become a wholly owned subsidiary of Menicon America Inc., effective as of June 14, 2010.
› Verified 7 days ago
| Entity Name | Essentia Health Moose Lake |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154959880 PECOS PAC ID: 6608290333 Enrollment ID: O20200730001548 |
News Archive
On Track Innovations Ltd., a global leader in contactless smart card solutions, has received an additional order for 100,000 MediSmartTM healthcare biometric ID cards for use by Kenyan-based Smart Applications International Ltd., a provider of technology driven secure healthcare solutions.
A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces the approval from the French Drug Agency (AFFSSaPS) to enter Phase II clinical trial for clonidine Lauriad® in radiotherapy and chemotherapy-induced oral mucositis and the approval from Danish and Slovene Agencies to enter Phase I clinical trial for AMEPTM in invasive melanoma.
Menicon Co., Ltd. announced on June 16 that Menicon and Lagado Corporation based in Colorado, USA, reached an agreement for Lagado to become a wholly owned subsidiary of Menicon America Inc., effective as of June 14, 2010.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rebecca Kortum Hartman, MD 400 E 3rd St, Duluth, MN 55805-1951 Ph: (218) 786-8364 | Dr Rebecca Kortum Hartman, MD 420 E 1st St, Duluth, MN 55805-1901 Ph: (218) 786-8364 |
News Archive
On Track Innovations Ltd., a global leader in contactless smart card solutions, has received an additional order for 100,000 MediSmartTM healthcare biometric ID cards for use by Kenyan-based Smart Applications International Ltd., a provider of technology driven secure healthcare solutions.
A comprehensive analysis of eight clinical trials and four cohort studies on cervical cancer screening by researchers from UC Davis and Kaiser Permanente Northwest has found that while Pap smears are still highly effective for detecting pre-cancerous cells and cancer, testing for the virus that causes these cancers also is an excellent screening tool.
BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces the approval from the French Drug Agency (AFFSSaPS) to enter Phase II clinical trial for clonidine Lauriad® in radiotherapy and chemotherapy-induced oral mucositis and the approval from Danish and Slovene Agencies to enter Phase I clinical trial for AMEPTM in invasive melanoma.
Menicon Co., Ltd. announced on June 16 that Menicon and Lagado Corporation based in Colorado, USA, reached an agreement for Lagado to become a wholly owned subsidiary of Menicon America Inc., effective as of June 14, 2010.
› Verified 7 days ago
Kirsten Ma Indrelie, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 Fax: 504-988-1846 | |
Dr. Andrea R Lays, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 420 E 1st St, Duluth, MN 55805 Phone: 218-786-8364 | |
Scott William Johnson, Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Haley Marie Meyer, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 | |
Aimee Nelson Van Straaten, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1000 E 1st St, Lower Level, Duluth, MN 55805 Phone: 218-722-5148 | |
Kelly Jo Greenleaf, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-3800 | |
William Gary Turner, Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 400 E 3rd St, Duluth, MN 55805 Phone: 218-786-8364 |